Poliovirus Therapy for Recurrent Glioblastoma Has Three-Year Survival Rate of 21 Percent
A genetically modified poliovirus therapy developed at The Preston Robert Tisch Brain Tumor Center shows significantly improved long-term survival...
We believe it takes all of us working together—doctors, nurses, researchers, donors, patients, friends and family. All are needed to make a difference in the lives of those for whom we care.
The Preston Robert Tisch Brain Tumor Center Blog provides updates, announcements and breaking news in science. This blog also highlights inspiring patient stories and the accomplishments and achievements of of our physicians and researchers. To stay informed of the latest news and receive top stories from our world-renowned brain tumor center, subscribe below now!